Navigation Links
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Date:7/18/2014

its executive officers may be considered participants in the solicitation of proxies in connection with the transactions contemplated by the Proxy Statement/Prospectus. Information about the directors and executive officers of AbbVie is set forth in its Annual Report on Form 10-K for the year ended December 31, 2013, which was filed with the SEC on February 21, 2014, and its proxy statement for its 2014 annual meeting of stockholders, which was filed with the SEC on March 24, 2014. Other information regarding potential participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the Proxy Statement/Prospectus when it is filed.

Forward-Looking Statements

This announcement contains certain forward-looking statements with respect to a possible combination involving AbbVie and Shire. The words "believe," "expect," "anticipate," "project" and similar expressions, among others, generally identify forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the possibility that a possible combination will not be pursued, failure to obtain necessary regulatory approvals or required financing or to satisfy any of the other conditions to the possible combination, adverse effects on the market price of AbbVie Shares and on AbbVie's or Shire's operating results because of a failure to complete the possible combination, failure to realise the expected benefits of the possible combination, negative effects relating to the announcement of the possible combination or any further announcements relating to the possible combination or the consummation of the possible combination on the market price of AbbVie shares or Shire shares, significant transaction costs and/or unknow
'/>"/>

SOURCE AbbVie Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Star Scientific and Rock Creek Pharmaceuticals Announce the Publication of a Peer-Reviewed Article about the ASAP Clinical Trial Showing Immune System Support in Hashimotos Thyroiditis
2. BioTechniques: The International Journal of Life Science Methods Announces the Publication of the October 2013 Digital Edition Now Available Online and in the App Store
3. Celladon Corporation Announces Publication of Long Term Follow-Up Results from the MYDICAR CUPID 1 Trial in Advanced Heart Failure
4. Labome: The Gateway to the Perfect Antibody -- Labome Antibody Review Database Has Now Reached 10,000 Peer-Reviewed Formal Publications
5. New Reporting Guidelines For Case Reports Presented At The Congress On Peer Review And Biomedical Publication And Published In Seven Medical Journals
6. Mucosis Announces Publication of Data Demonstrating Safety and Protection by Mucosally Administered Mimopath®-based Prefusion-like F RSV Vaccines
7. India Pharmaceutical Sector Reviewed by Kelly Scientific Publications in In-demand Report Now Available at MarketPublishers.com
8. Signal Genetics Announces Publication of BreastPRS™ Validation Study with Weill Cornell Medical College, New York
9. China Pharmaceutical Industry Examined in New Kelly Scientific Publications Report Available at MarketPublishers.com
10. MarketResearch.com Announces Distribution of Kelly Scientific Publications
11. Rosetta Genomics Announces Acceptance for Publication by Molecular Cancer of Rosetta Cancer Origin Test Manuscript
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... The "Operating Room Management Market ... Application (Perioperative, Preoperative, operating room Scheduling), by Component ... Global Forecast to 2019.” defines and segments the ... forecast of value by product, such as data ... the value and volumes of operating room management ...
(Date:11/15/2014)... 2014 The report “Laboratory ... End-User - Global Forecasts to 2019”, defines ... an analysis and forecast of value by ... Osmosis. Along with this, the value of ... regions are also discussed in the report. ...
(Date:11/15/2014)... 2014 Anthera Pharmaceuticals, Inc. (NASDAQ: ... for the third quarter ended September 30, 2014. ... September 30, 2014 was $7.0 million, compared to $5.8 ... in net loss is mainly driven by higher research ... progress in both our Phase 3 systemic lupus erythematosus ...
(Date:11/12/2014)... , 12. November 2014 /PRNewswire/ ... RaySafe, ist weltweit führend in der ... biomedizinische Tests und Simulationen und diagnostische ... Nach dem erfolgreichen ... nun branchenweit in Hinsicht auf Produktqualität, ...
Breaking Biology Technology:Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 2Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 3Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 4Laboratory Filtration Market worth $2,532.6 Million by 2019 - New Report by MarketsandMarkets 2Laboratory Filtration Market worth $2,532.6 Million by 2019 - New Report by MarketsandMarkets 3Laboratory Filtration Market worth $2,532.6 Million by 2019 - New Report by MarketsandMarkets 4Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 5Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 6Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 2Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 3Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 4Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 5
... Sept. 9 Energy crop company,Ceres, Inc. announced ... high-biomass sorghum hybrids with Range Fuels, Inc. as ... site of Range Fuels,commercial-scale cellulosic ethanol plant, now ... of Atlanta., While wood residues will be ...
... to ... economy, ... business development projects is being recognized by,Area Development magazine, which awarded ... awarded to states that have generated,top job-creation and capital investment projects ...
... chemistry Professor Harry Dorn has developed a new area of ... molecular semiconductors and quantum computing applications. , Dorn plays ... they are tinker toys. First, in 1999, he figured out ... to do it reliably, how to change the number of ...
Cached Biology Technology:Ceres Trials Energy Crops at Georgia Biofuel Facility 2Ceres Trials Energy Crops at Georgia Biofuel Facility 3Ohio Recognized as National Leader for Business Development and Job Creation 2Ohio Recognized as National Leader for Business Development and Job Creation 3Carbon molecule with a charge could be tomorrow's semiconductor 2
(Date:11/3/2014)... A University of Colorado Cancer Center study ... Academy of Sciences describes the activity of a ... Interleukin 37 or IL-37. It has been known to ... in the adaptive immune system: IL-37 inhibits the ability ... antigens. , "Knowing this mechanism that underlies IL-37,s effect ...
(Date:11/2/2014)... (2 November 2014)—In support of a bold quest to ... Melinda Gates Foundation today announced an award of US$156 ... Initiative (MVI) in building new vaccines that will interrupt ... the "accelerating to zero" agenda. Such vaccines would ensure ... be called an "immunological bed net." , This ...
(Date:10/31/2014)... largest producer of cocoa. Chocolate trees ( Theobroma cacao ... of rainforest in the state of Bahia, beneath a ... rainforest was a biodiversity hotspot, the chocolate trees, which ... in the mid 1700s, had very low levels of ... scenario created a very romantic, but extremely fragile situation". ...
Breaking Biology News(10 mins):PNAS: From HIV to cancer, IL-37 regulates immune system 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4Scientists seek cure for devastating witches' broom disease of the chocolate tree 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 3
... progression of a lethal type of brain tumor with reduced ... complex the immune response is to the cancer and the ... Previous research found that people with allergies were ... cancer, called glioblastoma multiforme. However, it was not clear whether ...
... improved snacks and a la carte offerings to meet ... physical activity did not improve in most schools, according ... the few states to collect and analyze plans to ... projects coordinator, Project PA. Project PA, a collaboration between ...
... EAST LANSING, Mich. States aiming to lead the ... subsidies and tax incentives to ethanol producers just to ... "State subsidies have played an important role in ... of agricultural, food and resource economics. "The size of ...
Cached Biology News:Brain tumor growth linked to lowered expression of hundreds of immune function genes 2Brain tumor growth linked to lowered expression of hundreds of immune function genes 3Pennsylvania makes inroads into reducing child obesity 2State biofuel subsidies costly but effective, MSU research shows 2
... The Aquarius 384 is a ... Aquarius 384-well head is a unique ... washing using the included wash system. ... 250 microplate stacker system. Will ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... it easy to supply microplates, deepwells, and ... operator convenience in mind, iLink incorporates multiple ... use. The iLink software is the key ... sub-assays, that can be copied and installed ...
... products bring you ease of use and rapid solutions to meet your laboratory's requirements for data ... ... ... CLARA® is the standard software for Staccato Systems ...
Biology Products: